bioAffinity Technologies, Inc. (BIAF) Press Releases https://ir.bioaffinitytech.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/bioaffinitytech/files/theme/images/logo-sm.png bioAffinity Technologies, Inc. Logo Equisolve Investor Relations Suite <![CDATA[bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/176/bioaffinity-technologies-cypath-lung-test-unit-sales Wed, 01 Apr 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/176/bioaffinity-technologies-cypath-lung-test-unit-sales <![CDATA[bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/175/bioaffinity-technologies-to-host-live-virtual-physician Wed, 25 Mar 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/175/bioaffinity-technologies-to-host-live-virtual-physician <![CDATA[New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/174/new-case-study-bioaffinity-technologies-cypath-lung Tue, 17 Mar 26 07:45:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/174/new-case-study-bioaffinity-technologies-cypath-lung <![CDATA[bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/173/bioaffinity-technologies-announces-record-2025-revenue-and Fri, 13 Mar 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/173/bioaffinity-technologies-announces-record-2025-revenue-and <![CDATA[bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/172/bioaffinity-technologies-announces-initiation-of Tue, 10 Mar 26 07:47:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/172/bioaffinity-technologies-announces-initiation-of <![CDATA[bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/171/bioaffinity-technologies-presents-positive-research Tue, 03 Mar 26 08:30:00 -0500 https://ir.bioaffinitytech.com/news-events/press-releases/detail/171/bioaffinity-technologies-presents-positive-research <![CDATA[bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/170/bioaffinity-technologies-announces-validation-study-with Wed, 25 Feb 26 08:30:00 -0500 https://ir.bioaffinitytech.com/news-events/press-releases/detail/170/bioaffinity-technologies-announces-validation-study-with <![CDATA[New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/169/new-case-study-highlights-ability-of-bioaffinity Thu, 19 Feb 26 11:00:00 -0500 https://ir.bioaffinitytech.com/news-events/press-releases/detail/169/new-case-study-highlights-ability-of-bioaffinity <![CDATA[Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/168/clinical-utility-of-bioaffinity-technologies-cypath Tue, 17 Feb 26 08:00:00 -0500 https://ir.bioaffinitytech.com/news-events/press-releases/detail/168/clinical-utility-of-bioaffinity-technologies-cypath <![CDATA[bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board]]> https://ir.bioaffinitytech.com/news-events/press-releases/detail/167/bioaffinity-technologies-appoints-nationally-recognized Mon, 09 Feb 26 08:00:00 -0500 https://ir.bioaffinitytech.com/news-events/press-releases/detail/167/bioaffinity-technologies-appoints-nationally-recognized